Marco van Staden

Ask VT AI
View News Summary
  • Gilead Sciences reports strong Q2 results, raises full-year guidance, and sees shares rise on the back of its HIV portfolio and new drug launches.
  • Krispy Kreme reports massive Q2 loss, triggering a turnaround plan focused on cost reduction and operational efficiency.
  • Tottenham suffer major blow as James Maddison suffers ruptured ACL, ruling him out for most of the 2025–26 season.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • Gilead Sciences reports strong Q2 results, raises full-year guidance, and sees shares rise on the back of its HIV portfolio and new drug launches.
  • Krispy Kreme reports massive Q2 loss, triggering a turnaround plan focused on cost reduction and operational efficiency.
  • Tottenham suffer major blow as James Maddison suffers ruptured ACL, ruling him out for most of the 2025–26 season.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from Marco van Staden